Submitted:
17 July 2024
Posted:
17 July 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- https://www.ecdc.europa.eu/sites/default/files/documents/CAMP_AER_2022_final.pdf.
- https://www.ecdc.europa.eu/sites/default/files/documents/EFS2_8442.pdf.
- Kaakoush, NO., Castaño-Rodríguez N., Mitchell HM., Man SM., 2015. Global epidemiology of Campylobacter infection. Clin Microbiol Rev,Vol 28, no 3. [CrossRef]
- Cardoso, MJ., Ferreira V., Truninger M., Maia R., Teixeira P., 2021. Cross-contamination events of Campylobacter spp. in domestic kitchens associated with consumer handling practices of raw poultry. International Journal of Food Microbiology, Volume 338. [CrossRef]
- Santos-Ferreira, N., Alves A., Cardoso MJ., Langsrud S., Malheiro AR., Fernandes R., et al., 2021. Cross-contamination of lettuce with Campylobacter spp. via cooking salt during handling raw poultry. PLoS ONE 16 (5). [CrossRef]
- Noreen, Z., Siddiqui F., Javed S., Wren BW., Bokhari H., 2020. Transmission of multidrug-resistant Campylobacter jejuni to children from different sources in Pakistan. Journal of Global Antimicrobial Resistance,Volume 20 Pages 219-224. [CrossRef]
- Kayman, T., Abay S., Aydin F., Şahin O., 2019. Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey. J Med Microbiol. 68 (2):136-142. [CrossRef]
- Myintzaw, P., Jaiswal AK., Jaiswal S., 2021. A Review on Campylobacteriosis Associated with Poultry Meat Consumption. Food Reviews International, vol. 39, no. 4, 2107–2121. [CrossRef]
- Whelan MVX., Ardill L., Koide K. et al.,2019. Acquisition of fluoroquinolone resistance leads to increased biofilm formation and pathogenicity in Campylobacter jejuni. Sci Rep 9. [CrossRef]
- Hormeño, L., Campos MJ., Vadillo S., Quesada A.,2020. Occurrence of tet(O/M/O) Mosaic Gene in Tetracycline-Resistant Campylobacter. Microorganisms. 31; 8(11):1710. [CrossRef]
- Konkel, M.E., Gray S.A., Kim B.J., Garvis S.T. and Yoon J., 1999. Identification of the enteropathogens Campylobacter jejuni and Campylobacter coli based on the cadF virulence gene and its products. Journal of Clinical Microbiology 37, 510–517. [CrossRef]
- Gonzalez, I., Grant K.A., Richardson P.T., Park S.F. and Collins M.D., 1997. Specific identification of the enteropathogens Campylobacter jejuni and Campylobacter coli by using a PCR test based on the ceuE gene encoding a putative virulence determinant. Journal of Clinical Microbiology 35, 759–763. [CrossRef]
- Bacon, DJ., Alm RA., Burr DH., Hu L., Kopecko DJ., Ewing CP., Trust TJ. and Guerry P., 2000. Involvement of a plasmid in virulence of Campylobacter jejuni 81–176. Infection and Immunity 68, 4384–4390. [CrossRef]
- Nachamkin, I., Bohachick K. and Patton CM., 1993a. Flagellin gene typing of Campylobacter jejuni by restriction fragment length polymorphism analysis. Journal of Clinical Microbiology 31, 1531– 1536. [CrossRef]
- Pickett, C.L., Pesci E.C., Cottle D.L., Russell G., Erdem A.N. and Zeytin H., 1996. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter spp. cdtB genes. Infection and Immunity 64, 2070–2078. [CrossRef]
- Zirnstein, G., LI Y., Swaminathan B. and Angulo F., 1999. Ciprofloxacin Resistance in Campylobacter jejuni Isolates: Detection of gyrA Resistance Mutations by Mismatch Amplification Mutation Assay PCR and DNA Sequence Analysis. Journal of Clinical Microbiology,Vol.37,Nr.10p.3276–3280. [CrossRef]
- Alonso, R., Mateo E., Churruca E., Martinez I, Girbau, Fernandez-Astorga A., 2005. MAMA-PCR assay for the detection of point mutations associated with high-level erythromycin resistance in Campylobacter jejuni and Campylobacter coli strains. Journal of Microbiological Methods 63 99– 103. ttps://doi.org/10.1016/j.mimet.2005.03.013.
- Gibreel, A., Tracz DM., Nonaka L., Ngo TM., Connell SR., and Taylor DE., 2004. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet (O)-mediated tetracycline resistance. Antimicrobial Agents and Chemotherapy, vol. 48, no. 9, pp. 3442–3450. [CrossRef]
- Wang, Y., Wai Mun Huang W.M.H. and Taylor DE., 1993. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrobial Agents and Chemotherapy, vol. 37, no. 3, pp. 457– 463. [CrossRef]
- Dingle, KE., Colles FM., Wareing DRA., Ure R., Fox A.J., Bolton FE., Bootsma HJ., Willems RJL., Urwin R., and Maiden MCJ., 2001. Multilocus sequence typing system for Campylobacter jejuni. J. Clin. Microbiol. 39:14–23. [CrossRef]
- Parkhill, J., Wren BW., Mungall K., Ketley JM., Churcher C., Basham D., Chillingworth T., Davies RM., Feltwell T., Holroyd S., Jagels K., Karlyshev AV., Moule S., Pallen MJ., Penn CW., Quall MA., Rajandream MA., Rutherford KM.,van Vliet AHM., Whitehead S. and Barrell BG., 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403, 665–668. [CrossRef]
- Panzenhagen, P., Portes A.B., dos Santos AMP, Silva Duque S. and Conte Junior CA., 2021.The Distribution of Campylobacter jejuni Virulence Genes in Genomes Worldwide Derived from the NCBI PathogenDetection Database. Genes 12, 1538. [CrossRef]
- Kayman, T., Abay S., Aydin F., Şahin O.,2019. Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey. J Med Microbiol.,68(2):136-142. [CrossRef]
- Connell, SR., Trieber CA., Dinos GP., Einfeldt E., Taylor DE. and Nierhaus KH., 2003. Mechanism of Tet(O)-mediated tetracycline resistance. EMBO Journal, vol. 22, no. 4, pp. 945– 953. [CrossRef]
- Roberts, MC., 2005. Update on acquired tetracycline resistance genes. FEMS Microbiol lett 245: 195-203. [CrossRef]
- Luangtongkum, T., Jeon B., Han J., Plummer P., Logue C., Zhang Q., 2009. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol 4: 189-200. [CrossRef]
- Ge, B., Wang F, Sjolund-Karlsson M., McDermott P., 2013. Antimicrobial resistance in Campylobacter: susceptibility testing methods and resistance trends. J Microbiol Methods 95: 57-67.
- http://atlas.ecdc.europa.eu/public/index.aspx.
- Maiden MCJ., 2000. High-throughput sequencing in the population analysis of bacterial pathogens. Int. J.Med. Microbiol. 290:183–190. [CrossRef]
- Altekruse, SF., Stern NJ., Fields PI., Swerdlow DL., 1999. Campylobacter jejuni an emerging foodborne pathogen. Emerg. Infect. Dis. 5:28–35. [CrossRef]




| Target gene | primer sequence 5ˈ- 3ˈ amplicon length |
Reference | ||
|---|---|---|---|---|
| Virulece | CadF | F2B:5ˈTGGAGGGTAATTTAGATATG3ˈ R1B:5ˈCTAATACCTAAAGTTGAAAC3ˈ - 400pb |
- 94°C 1 min -45°C 1min x 30 -72°C 3min |
Konkel et al., 1999 [11] |
| CeuE | JEJ1:5ˈCCTGCTCGGTGAAAGTTTTG3ˈ JEJ2:5ˈGATCTTTTTGTTTTGTGCTGC3ˈ - 794 bp |
-93°C 3 min - 95°C 30 sec -57°C 30 sec x 30 -72°C 1min |
Gonzalez et al., 1997 [12] | |
| virB11 | VirBF:5ˈGAACAGGAAGTGGAAAAACTAGC-3ˈ VirBR:5ˈTTCCGCATTGGGCTATATG-3ˈ - 708 bp |
-95°C 2min - 95°C 30 sec -52°C 30 sec x 35 -72°C 1min |
Bacon et al., 2000 [13] | |
| flaA | flaAF:5ˈGGATTTCGTATTAACACAAATGGTGC3ˈ flaAR:5ˈCTGTAGTAATCTTAAAACATTTTG3ˈ - 1728 bp |
- 94°C 1min - 45°C 1 min x 30 - 72°C3min |
Nachamkim et al., 1993a [14] |
|
|
cdtA cdtB cdtC |
GNW:5ˈGGAAATTGGATTTGGGGCTATACT-3ˈ IVH:5ˈATCACAAGGATAATGGACAAT-3ˈ - 165bp VAT2: 5ˈ GTTAAAATCCCCTGCTATCAACCA 3ˈ WMI-R:5ˈGTTGGCACTTGGAATTTGCAAGGC3ˈ - 495bp WMI-F:5ˈTGGATGATAGCAGGGGATTTTAAC3ˈ LPF-X:5ˈTTGCACATAACCAAAAGGAAG-3ˈ - 555 bp |
- 94°C 1min - 42°C 1 min x 30 -72°C3min |
Pickett et al., 1996 [15] |
|
| Resistance | GZgyrA5 GZgyrA6 used for sequencing GZgyrA7 GZgyrA8 |
F: ATTTTTAGCAAAGATTCTGAT R: CCATAAATTATTCCACCTGT - 673 pb F:TTATTATAGGTCGTGCTTTG R:TAGAAGGTAAAACATCAGGTT |
- 94°C 3min - 94°C 1 min - 50°C 1 min x 30 -72°C 3min -72°C 5min - 96°C 2 min - 96°C 20 sec -50°C 20 sec x 40 -60°C 4 min |
Gerald Zirnstein et al.,1999. [16] |
|
23S ARN-F ERY2074-R |
F: TTAGCTAATGTTGCCCGTACCG R: AGTAAAGGTCCACGGGGTCTGG - 485 pb |
- 95°C 5min - 94°C 30 sec - 59°C 30 sec x 30 -72°C 45 sec -72°C 5min |
Alonso et al., 2005 [17] |
|
|
23S ARN-F ERY2075-R used for sequencing 23S ARN-F 23S ARN-R |
F: TTAGCTAATGTTGCCCGTACCG R: TAGTAAAGGTCCACGGGGTCGC - 485 pb F:TTAGCTAATGTTGCCCGTACCG R: AGCCAACCTTTGTAAGCCTCCG |
- 95°C 5min - 94°C 30 sec - 59°C 30 sec x 30 -72°C 45 sec -72°C 5min |
Alonso et al., 2005 [17] |
|
| tetO | DMT1 DMT2 559pb |
- 95°C 5min - 94°C 1 min - 57°C 1 min x 30 -72°C 1 min -72°C 5min |
Gibreel A et al, 2004 [18] |
| species | source | no. of positive PCRs | ||||||
|---|---|---|---|---|---|---|---|---|
|
Campylobacter jejuni |
co-culture | cadF | ceuE | virB11 | flaA | cdtA | cdtB | cdtC |
| 66+/66 | 66+/66 | 14+/66 | 66+/66 | 62+/66 | 65+/66 | 65+/66 | ||
| % | 100% | 100% | 21% | 100% | 93% | 98% | 98% | |
| locus | forward primer | reverse primer | amplicon size |
|---|---|---|---|
| aspA | amplification: A9 AGTACTAATGATGCTTATCC |
A10 ATTTCATCAATTTGTTCTTTGC | 899 pb |
| sequencing: S3 CCAACTGCAAGATGCTGTACC |
S6 TTCATTTGCGGTAATACCATC | ||
| glnA | amplification: A1 TAGGAACTTGGCATCATATTACC |
A2 TTGGACGAGCTTCTACTGGC | 1262 pb |
| sequencing: S3 CATGCAATCAATGAAGAAAC |
S6 TTCCATAAGCTCATATGAAC | ||
| gltA | amplification: A1 GGGCTTGACTTCTACAGCTACTTG |
A2 CCAAATAAAGTTGTCTTGGACGG | 1012 pb |
| sequencing: S3 CTTATATTGATGGAGAAAATGG |
S6 CCAAAGCGCACCAATACCTG | ||
| glyA | amplification: A1 GAGTTAGAGCGTCAATGTGAAGG |
A2 AAACCTCTGGCAGTAAGGGC | 816 pb |
| sequencing: S3 AGCTAATCAAGGTGTTTATGCGG |
S4 AGGTGATTATCCGTTCCATCGC | ||
| tkt | amplification: A3 GCAAACTCAGGACACCCAGG |
A6 AAAGCATTGTTAATGGCTGC | 1102 pb |
| sequencing: S5 GCTTAGCAGATATTTTAAGTG |
S6 AAGCCTGCTTGTTCTTTGGC | ||
| pgm | amplification: A3 TCAGGGCTTACTTCTATAGG |
A4 AGCTTAATATCTCTGGCTTC | 1150 pb |
| sequencing: S5 GGTTTTAGATGTGGCTCATG |
S2 TCCAGAATAGCGAAATAAGG | ||
| uncA | amplification: A7ATGGACTTAAGAATATTATGGC |
A4 ATTCTTTGTCCACGTTCAAG | 1120 pb |
| sequencing: S3 AAAGTACAGTGGCACAAGTGG | S4 TGCCTCATCTAAATCACTAGC |
| locus | fragment size | no alleles/ frequency |
| aspA | 477 pb | 12 alleles(allele 8,9,2 and 7) |
| glnA | 477 pb | 14 alleles(allele 17 and 2) |
| gltA | 402 pb | 11 alleles(allele 2 and 5) |
| glyA | 507 pb | 17 alleles(allele 2,10, and 838 -new allele) |
| pgm | 498 pb | 16 alleles(allele 11 and 10) |
| tkt | 459 pb | 16 alleles(allele 5,3 and 1) |
| uncA | 489 pb | 13 alleles(allele 6,5 and 632-new allele) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).